Navigation Links
Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets
Date:10/26/2011

SAN FRANCISCO, Oct. 26, 2011 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2011 on Wednesday, November 2, 2011, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Thursday, December 1, 2011. To access the conference call, follow these instructions:Dial: (866) 203-3436 (U.S.); (617) 213-8849 (international)Passcode: 16610535 (Nektar Therapeutics is the host)An audio replay will also be available shortly following the call through Thursday, December 1, 2011 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 41636531.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for NKTR-118, an investigationa
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
2. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
3. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
4. Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets
5. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
6. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
7. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
8. Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets
9. Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
10. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
11. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... Aug. 31, 2015  On August 5, 2015, the ... Oregon denied motions to dismiss securities class ... ) and certain of its directors. The class actions ... and dump" scheme to artificially inflate Galena,s stock price, ... stock price was inflated, sold massive amounts of their ...
(Date:8/31/2015)... -- Regen BioPharma, Inc. (OTCBB: RGBP) and (PINK: ... of delivering its patented (US Patent 8,263,571) gene ... a clinically approved formulation as delivery system.  The ... silencing therapeutics in which the gene silencing drug ... By utilizing a local delivery system, potential toxicities ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... FREDERICKSBURG, Va., Feb. 17, 2011 Radiologic Associates ... Gently Campaign to increase awareness of opportunities to lower ... initiative of the Alliance for Radiation Safety in Pediatric ... undergone additional training in ways to reduce radiation exposure, ...
... Feb. 17, 2011 The method represented in the ... respiratory arterial pressure wave (a blood wave that ... blood pressure readings to provide healthcare professionals and users ... on systemic blood pressure. (Logo: ...
Cached Medicine Technology:Radiologic Associates of Fredericksburg Announces Image Gently Campaign to 'Child Size' Doses for Children 2ICAP Ocean Tomo Announces Advanced Techniques for Measuring Blood Pressure From Coherence L.L.C. 2
(Date:8/31/2015)... Plains, NJ (PRWEB) , ... August 31, 2015 , ... ... as an “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical and ... orthopedics and traumatic injuries to the entire musculoskeletal system, excluding the spine. , Dr. ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... digital marketing communications company announced today that it has officially launched a new ... the new website and brand refresh are more closely aligned with the company’s ...
(Date:8/31/2015)... ... August 31, 2015 , ... Finnleo is pleased to announce ... Sauna. After months of extensive engineering and design of our newest sauna model, the ... elements and is offered at a very attractive price-point. , Before outdoor saunas ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement (CDI) and medical ... a patent pending ICD-10 solution - ezCAC is an enterprise-level coding solution that ...
(Date:8/31/2015)... Valley, CA (PRWEB) , ... August 31, 2015 , ... ... Ghasri, to the practice. Dr. Pedram Ghasri is a graduate of the University of ... neuroscience and continued his studies at the University of California, Irvine Medical School. As ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2
... of outdated inspection practices desperately needed, critics say ... system that guarantees the safety of food in the ... new report finds. , Gaps in the food safety ... inconsistencies among agencies protecting food safety, according to the ...
... have a significantly higher risk of developing Alzheimers ... remains unexplained. Now, researchers at the Salk Institute ... for the diabetes Alzheimers interaction. , In ... of Neurobiology of Aging, investigators led by David ...
... becoming three kinds of cardiac cells , , WEDNESDAY, April ... created from mouse skin cells reprogrammed to have the ... researchers at the University of California, Los Angeles. ... induced pluripotent stem (iPS) cells, which don,t involve the ...
... Actually Work in Real ... ... healthcare community, announced the launch of an,innovative new tool that brings patient ... drugs, and eight out of,ten surfing the web for their healthcare information, ...
... lifestyles, WASHINGTON, April 29 Blue Cross ... of all sizes to get,their workers to take ... inactive lifestyles and preventable health conditions,have on the ... companies,are holding lunchtime walks across America as part ...
... Inc.,(NYSE: HI ) today announced that its Board ... traded company of $0.1825 per share,on the company,s common ... of record at the close of business on June ... approve this inaugural dividend is based,on the strength of ...
Cached Medicine News:Health News:Report Slams U.S. Food Safety System 2Health News:Report Slams U.S. Food Safety System 3Health News:Report Slams U.S. Food Safety System 4Health News:Salk study links diabetes and Alzheimer's disease 2Health News:Salk study links diabetes and Alzheimer's disease 3Health News:Mouse Skin Cells Reprogrammed to Act Like Embryonic Stem Cells 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 2Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 4Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 5Health News:Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company 2
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
... B3 Triplanar hip joint is ... - extension, abduction - Ad-duction, ... our Boston Post-Op Hip Orthosis. ... custom Hip Spicas in both ...
... advance in walker design in years. A real step ... bearing surfaces of the foot rest on adaptive areas ... heel strike. The footbed in the sole conforms to ... and stability. , ,No leg length discrepancy; Heel ...
... The High Tide walker provides comfortable stability ... of the lower leg, stress fractures of ... fractures of the ankle. Extension pads for ... patients.The shorter Low Tide walker with midcalf ...
Medicine Products: